• RDIF, Hualan Ink COVID-19 Vaccine Deal contractpharma
    April 20, 2021
    The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Hualan Biological Bacterin Inc., a subsidiary company of one of China’s leading biopharmaceutical producers and the largest influenza vaccine manufacturer ...
PharmaSources Customer Service